Clinical Trials Logo

Clinical Trial Summary

To evaluate the effect of intramuscular RZV vaccine on VZV-specific skin TRM and circulating T-cells


Clinical Trial Description

This is an interventional study of vaccination related to infection with varicella zoster virus. We will enroll participants of two age groups. Cohort 1 will be persons between the ages of 30-40; Cohort 2 will be persons who are 70 years of age or older. All participants will receive the FDA-approved recombinant zoster (RZV) vaccine (Shingrix) given at the approved dose and schedule. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04403139
Study type Interventional
Source University of Washington
Contact Virology Research Clinic
Phone 206-520-4340
Email vrc@uw.edu
Status Recruiting
Phase Phase 4
Start date April 27, 2022
Completion date February 2025

See also
  Status Clinical Trial Phase
Completed NCT01682109 - Palatability Testing of a New Paediatric Formulation of Valacyclovir Phase 4
Recruiting NCT05198570 - Pharmacokinetics of Intravenous Acyclovir in Oncologic Paediatric Patients
Not yet recruiting NCT06409494 - Clinical Trial to Evaluate EuHZV in Healthy Adults Aged 50 to 69 Years Phase 1
Recruiting NCT05532540 - Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant Study
Recruiting NCT05604911 - Herpes Virus Infections in Kidney Transplant Patients
Not yet recruiting NCT05664152 - An Open-label, Bridging Study of BARYCELA Inj. in Healthy Vietnamese Children Aged Between 12 Months to 12 Years N/A
Completed NCT01689285 - Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of Valacyclovir Phase 1
Terminated NCT04081480 - Pharmacokinetics of Valacyclovir Oral Solution in Children N/A